Physician profile
Richard Dowd
NPI 1528446465
$12,409.06
in general payments reported to CMS, 2019-2025
9 companies · $12K in 2025
The $12K reported for 2025 was more than what 87% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $201 · 2024: $25.03 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $2,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,148.54 |
| Food and Beverage | $2,260.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $3,386.53 | 2025 | |
| Medtronic, INC. | $3,220.91 | 2023-2025 | Mazor X System, Stealthstation S8 Platform |
| Vb Spine LLC | $2,798.47 | 2025 | Niagara Lateral Access System, Cascadia Interbody System, Everest Spinal System |
| Alphatec Spine, INC | $2,777.12 | 2025 | Other - Miscellaneous, Invictus Mis |
| Orthofix Medical, INC. | $78.71 | 2023 | 7d Surgical System |
| Medical Device Business Services, INC. | $68.50 | 2025 | Velys |
| Stryker Corporation | $31.50 | 2025 | N/A |
| Boston Scientific Corporation | $25.03 | 2024 | |
| Novocure INC. | $22.29 | 2025 | Optune Gio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Dowd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.